Gordon H. Guyatt
@GuyattGH
Promoting use of the best evidence and patient values and preferences to inform optimal clinical and health policy decisions. https://t.co/JxbX7cZMgy
ID:2559531679
https://www.linkedin.com/in/guyattgh/ 10-06-2014 18:19:48
4,3K Tweets
13,5K Followers
565 Following
Two articles highlight big problems when platform trials include non-contemporaneous controls. In addressing A vs no A, analysis should only use randomizations that included possibility of A. Should never use controls of B vs non-B.
nejm.org/doi/full/10.10…
sciencedirect.com/science/articl…
Latest evidence of utter failure of non-inferiority trials to set appropriate non-inferiority margins. Clinicians should ignore these margins & statistical claims of non-inferiority & instead think how their patients would balance benefits/harms/burdens. pubmed.ncbi.nlm.nih.gov/37421996/
After revisions for regulators, we're just about to start recruitment for large, pragmatic #ARTStrial that recruits uro, gyne & abdominal surgery patients in which net benefit of pharmacologic prophylaxis uncertain. If interested, please comment or message #EBM #EAU24 European Association of Urology (EAU)